April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Noemi Reguart: First Global Phase 3 Trial Showing Substantial Survival Advantage Over Chemotherapy in SCLC
Apr 13, 2025, 17:50

Noemi Reguart: First Global Phase 3 Trial Showing Substantial Survival Advantage Over Chemotherapy in SCLC

Noemi Reguart, Medical Oncologist at Hospital Clinic Barcelona, shared a post on X:

“First global Phase 3 trial to show a substantial survival advantage over chemo in 2L SCLC!

Tarlatamab significantly improves OS after progression on platinum-based chemo.

Full topline results.”

More posts featuring SCLC.